Enhancing laboratory biosafety management: a comprehensive strategy from theory to practice.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 27 05 2024
accepted: 10 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: epublish

Résumé

This study examines biosafety management practices in a psychiatric hospital's laboratory in China, focusing on how outdated information technology impacts the hospital's ability to respond to public health emergencies. The goal is to enhance the hospital's emergency response capabilities by updating risk assessments, biosafety manuals, and implementing a comprehensive quality management system alongside a specialized infection control system for significant respiratory diseases. We utilized an integrated research approach, expanding the scope of risk assessments, updating the biosafety manual according to the latest international standards, and implementing a quality management system. A specialized infection control system for significant respiratory diseases was introduced to improve emergency response capabilities. Updated risk assessments and a new biosafety manual have significantly improved the identification and management of biosafety threats. Implementing new quality management and infection control systems has enhanced response efficiency and operational standardization. The measures taken have strengthened the biosafety management and emergency response capabilities of the laboratory department, highlighting the importance of information technology in biosafety management and recommending similar strategies for other institutions.

Identifiants

pubmed: 39371211
doi: 10.3389/fpubh.2024.1439051
pmc: PMC11449891
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1439051

Informations de copyright

Copyright © 2024 Tang, Yan, Yuan, Tang, Chen, Sun, Yang and Song.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Qin Tang (Q)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Fei Yan (F)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Lu Yuan (L)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Ying Tang (Y)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Hui Chen (H)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

YuTing Sun (Y)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Mi Yang (M)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

GuoLin Song (G)

Department of Clinical Laboratory, The Fourth People's Hospital of Chengdu, Chengdu, China.
MOE Key Lab for Neuroinformation, Department of Clinical Laboratory, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH